日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy

在 Sparsentan 治疗 IgA 肾病的 3 期 PROTECT 试验中，完全蛋白尿缓解与肾功能之间的关联

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000961
Heerspink, Hiddo J L; Rovin, Brad H; Komers, Radko; Hendry, Bruce; Mercer, Alex; Preciado, Priscila; Murphy, Edward; Tesar, Vladimir
IgA
TEC
发表日期：2026
文献求助 收藏

Antiproteinuric Effect of Sparsentan in Patients with Genetic-Associated FSGS Enrolled in the DUPLEX Trial

Sparsentan 对 DUPLEX 试验中入组的遗传相关性 FSGS 患者的抗蛋白尿作用

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000948
Yee, Jennifer; Gong, Wu; Inrig, Jula; Rheault, Michelle N; Gruber, Angela J; Bedard, Patricia W; Komers, Radko; Trachtman, Howard
发表日期：2026
文献求助 收藏

Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis

蛋白尿作为局灶节段性肾小球硬化症临床试验的终点

期刊:American Journal of Kidney Diseases
影响因子:8.2
doi:10.1053/j.ajkd.2024.08.011
Mariani, Laura H; Trachtman, Howard; Thompson, Aliza; Gillespie, Barbara S; Denburg, Michelle; Diva, Ulysses; Geetha, Duvuru; Greasley, Peter J; Hladunewich, Michelle A; Huizinga, Robert B; Inrig, Jula K; Komers, Radko; Laurin, Louis-Philippe; Little, Dustin J; Nachman, Patrick H; Smith, Kimberly A; Walsh, Liron; Gibson, Keisha L
发表日期：2025
文献求助 收藏

Framework for precision medicine in focal segmental glomerulosclerosis: Translation of sparsentan-responsive genes in a rat model to kidney disease associated proteins in biofluids

局灶节段性肾小球硬化症精准医疗框架：大鼠模型中稀疏单核细胞增多反应基因向生物体液中肾脏疾病相关蛋白的转化

期刊:
影响因子:
doi:10.1101/2025.02.26.25322958
Eddy, Sean; Nair, Viji; Hartman, John; Fermin, Damian; Eichinger, Felix; Godfrey, Bradley; Ju, Wenjun; Hodgin, Jeffrey B; Mariani, Laura H; Bedard, Patricia W; Jenkinson, Celia P; Hendry, Bruce; Komers, Radko; Inrig, Jula; Kretzler, Matthias
单核细胞
细胞生物学
Rat
发表日期：2025
文献求助 收藏

Sparsentan in IgA nephropathy: a plain language summary of publication for the PROTECT study

IgA肾病中的稀疏烷：PROTECT研究出版物的简明语言摘要

期刊:Therapeutic Advances in Rare Disease
影响因子:
doi:10.1177/26330040251355613
Rovin, Brad H; Komers, Radko; Scroggins, Chris; Barratt, Jonathan
IgA
TEC
发表日期：2025
文献求助 收藏

Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease

稀疏肽在肾脏中的保护机制：来自慢性肾脏病模型研究的启示

期刊:Clinical Science
影响因子:7.7
doi:10.1042/CS20240249
Kohan, Donald E; Bedard, Patricia W; Jenkinson, Celia; Hendry, Bruce; Komers, Radko
发表日期：2024
文献求助 收藏

Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study

Sparsentan 3期DUPLEX研究中局灶节段性肾小球硬化症患者的基线特征

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2024.01.032
Trachtman, Howard; Radhakrishnan, Jai; Rheault, Michelle N; Alpers, Charles E; Barratt, Jonathan; Heerspink, Hiddo J L; Noronha, Irene L; Perkovic, Vlado; Rovin, Brad; Trimarchi, Hernán; Wong, Muh Geot; Mercer, Alex; Inrig, Jula; Rote, William; Murphy, Ed; Bedard, Patricia W; Roth, Sandra; Bieler, Stewart; Komers, Radko
发表日期：2024
文献求助 收藏

Sparsentan for Focal Segmental Glomerulosclerosis in the DUET Open-Label Extension: Long-term Efficacy and Safety

Sparsentan治疗局灶节段性肾小球硬化症的DUET开放标签扩展研究：长期疗效和安全性

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2024.100833
Campbell, Kirk N; Gesualdo, Loreto; Murphy, Edward; Rheault, Michelle N; Srivastava, Tarak; Tesar, Vladimir; Komers, Radko; Trachtman, Howard
发表日期：2024
文献求助 收藏

IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study

Sparsentan PROTECT 研究中 IgA 肾病患者的基线特征

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2023.02.1086
Barratt, Jonathan; Rovin, Brad; Wong, Muh Geot; Alpers, Charles E; Bieler, Stewart; He, Ping; Inrig, Jula; Komers, Radko; Heerspink, Hiddo J L; Mercer, Alex; Noronha, Irene L; Radhakrishnan, Jai; Rheault, Michelle N; Rote, William; Trachtman, Howard; Trimarchi, Hernán; Perkovic, Vlado
IgA
TEC
发表日期：2023
文献求助 收藏

Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis: Sparsentan DUET Trial

局灶节段性肾小球硬化症患者任何时间点完全蛋白尿缓解的意义：Sparsentan DUET试验

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2023.07.022
Trachtman, Howard; Diva, Ulysses; Murphy, Edward; Wang, Kaijun; Inrig, Jula; Komers, Radko
发表日期：2023
文献求助 收藏